# Relmada Therapeutics, Inc.: Form 8-K, filed Mar 23, 2022

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2022-03-23
- Accepted by EDGAR: Mar 23, 2022, 16:23 ET
- Period: 2022-03-23
- Accession: 0001213900-22-014492
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390022014492/ea157328-8k_relmadathe.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390022014492/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390022014492/ea157328-8k_relmadathe.htm

Filed Mar 23, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-014492. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
